Microbiotica Overview

  • Founded
  • 2016
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $5.23M
Latest Deal Amount
  • Investors
  • 3

Microbiotica General Information


Developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and in vivo models.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Biodata Innovation Centre
  • Wellcome Genome Campus
  • Cambridge CB10 1DR
  • England, United Kingdom

Microbiotica Timeline

Date FoundedFinancing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Microbiotica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 24-Oct-2018 $5.23M 000.00 Completed Generating Revenue
1. Seed Round 15-Dec-2016 0000 0000 00.000 Completed Generating Revenue

Microbiotica Cap Table

To view Microbiotica‘s complete cap table, request access »
Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000

Microbiotica Executive Team (6)

Name Title Board Seat Contact Info
Mike Romanos Ph.D Co-Founder, Chief Executive Officer & Board Member
Trevor Lawley Ph.D Co-Founder, Board Member & Chief Scientific Officer
Thomas Mitchell Executive
Gordon Dougan Co-Founder
Samuel Williams Ph.D Non-Executive Investor Director

Microbiotica Board Members (6)

To view Microbiotica‘s full board member team, request access »
Name Representing Role Since
Iain Wilcock Self Board Member & Investment Director 000 0000
John Shields Ph.D Self Board Member 000 0000
Mike Romanos Ph.D Microbiotica Co-Founder, Chief Executive Officer & Board Member 000 0000
Robert Tansley MD Cambridge Innovation Capital Board Member 000 0000
Thomas Lynch Microbiotica Non-Executive Chairman 000 0000

Microbiotica Investors (3)

To view Microbiotica‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Seventure Partners Venture Capital Minority 000 0000 000000 0
Cambridge Innovation Capital Venture Capital Minority 000 0000 000000 0
IP Group Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial